EMvision Medical Devices (EMV.AX) Stock Price

EMvision Medical Devices Price

🇦🇺ASX·CLOSED
1.54AUD
Market closed
Today +/-
Today %

EMvision Medical Devices (EMV.AX) Stock | ISIN AU0000028375. The current EMvision Medical Devices stock price is 1.54 AUD (2026). Revenue is 5.56 M AUD. Net income is -9.2 M AUD. The P/E ratio is -14.35. Market capitalization is 143.59 M AUD. EMvision Medical Devices operates in the Health sector.

Over the last 7 years EMvision Medical Devices grew revenue by 41.6% annually, reaching 5.63 M AUD. For EMvision Medical Devices, the net margin of -174.2% is up versus -1,630.5% a few years ago.

EMvision Medical Devices stock price

Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of EMvision Medical Devices over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how EMvision Medical Devices stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing EMvision Medical Devices's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

EMvision Medical Devices Stock Price History
DateEMvision Medical Devices Price
Access this data via the Eulerpool API

EMvision Medical Devices Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
492,700 AUD
-844,600 AUD
-845,000 AUD
Jan 1, 2019
1.14 M AUD
-3.24 M AUD
-2.96 M AUD
Jan 1, 2020
980,700 AUD
-4.13 M AUD
-3.48 M AUD
Jan 1, 2021
515,100 AUD
-9.67 M AUD
-8.4 M AUD
Jan 1, 2022
4.38 M AUD
-6.09 M AUD
-6.11 M AUD
Jan 1, 2023
7.09 M AUD
-3.84 M AUD
-3.87 M AUD
Jan 1, 2024
11.56 M AUD
-1.92 M AUD
-2.73 M AUD
Jan 1, 2025
5.63 M AUD
-8.27 M AUD
-9.81 M AUD
Invalid Date
5.56 M AUD
-8.99 M AUD
-9.2 M AUD
Invalid Date
5.05 M AUD
-11.95 M AUD
-10.61 M AUD
Invalid Date
8.63 M AUD
-14.52 M AUD
-12.02 M AUD

EMvision Medical Devices Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jun 17, 2026, 9:49 AM
 
REVENUE (M AUD)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M AUD)
NET INCOME (M AUD)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
202120222023202420252026e2027e2028e
047115558
7557.14-54.5560
-------
00000000
-8-6-3-2-9-9-10-12
166.67-25-50-33.3335011.1120
70.175.1977.7180.4485.4485.4485.4485.44
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales EMvision Medical Devices generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue EMvision Medical Devices retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare EMvision Medical Devices's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares EMvision Medical Devices has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against EMvision Medical Devices's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

EMvision Medical Devices stock margins

The EMvision Medical Devices margin analysis displays the gross margin, EBIT margin, as well as the profit margin of EMvision Medical Devices. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for EMvision Medical Devices.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
0 %
-171.42 %
-171.5 %
Jan 1, 2019
0 %
-285.18 %
-260.67 %
Jan 1, 2020
0 %
-421.42 %
-354.42 %
Jan 1, 2021
0 %
-1,877.21 %
-1,630.5 %
Jan 1, 2022
0 %
-139.2 %
-139.61 %
Jan 1, 2023
0 %
-54.08 %
-54.57 %
Jan 1, 2024
0 %
-16.58 %
-23.61 %
Jan 1, 2025
0 %
-146.88 %
-174.21 %
Invalid Date
0 %
-161.82 %
-165.6 %
Invalid Date
0 %
-236.58 %
-210.04 %
Invalid Date
0 %
-168.35 %
-139.31 %

EMvision Medical Devices Stock Revenue, EBIT, Earnings per Share

The EMvision Medical Devices earnings per share therefore indicates how much revenue EMvision Medical Devices has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
0.01 AUD
-0.01 AUD
-0.01 AUD
Jan 1, 2019
0.02 AUD
-0.06 AUD
-0.05 AUD
Jan 1, 2020
0.02 AUD
-0.07 AUD
-0.06 AUD
Jan 1, 2021
0.01 AUD
-0.14 AUD
-0.12 AUD
Jan 1, 2022
0.06 AUD
-0.08 AUD
-0.08 AUD
Jan 1, 2023
0.09 AUD
-0.05 AUD
-0.05 AUD
Jan 1, 2024
0.14 AUD
-0.02 AUD
-0.03 AUD
Jan 1, 2025
0.07 AUD
-0.1 AUD
-0.11 AUD
Invalid Date
0.06 AUD
-0.11 AUD
-0.1 AUD
Invalid Date
0.05 AUD
-0.14 AUD
-0.11 AUD
Invalid Date
0.09 AUD
-0.17 AUD
-0.13 AUD

EMvision Medical Devices business model & stock analysis

EMvision Medical Devices Ltd. engages in the development & commercialization of medical imaging technology. The company is headquartered in Sydney, New South Wales. The company went IPO on 2018-12-13. The firm is engaged in the research and development of medical imaging and diagnostic technology (the EMVision Technology), for the purpose of commercializing a portable medical device for stroke diagnosis and monitoring as well as other medical imaging needs. The firm is developing and commercializing medical imaging diagnostics for various disease states and medical emergencies. The Company’s product pipeline includes portable, non-invasive, neuroimaging devices. Its lead product in development includes a portable, non-ionizing brain scanner, capable of producing images of biological tissue to provide insights for clinicians. Its second-generation device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location.

EMvision Medical Devices Eulerpool Fair Value

EMvision Medical Devices historical P/E ratio, EBIT multiple, and P/S ratio

EMvision Medical Devices annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

EMvision Medical Devices shares outstanding

The number of shares was EMvision Medical Devices in 2025 — This indicates how many shares 85.443 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
57.58 M base_Shares
Jan 1, 2019
57.58 M base_Shares
Jan 1, 2020
62.07 M base_Shares
Jan 1, 2021
70.1 M base_Shares
Jan 1, 2022
75.19 M base_Shares
Jan 1, 2023
77.71 M base_Shares
Jan 1, 2024
80.44 M base_Shares
Jan 1, 2025
85.44 M base_Shares
Invalid Date
85.44 M base_Shares
Invalid Date
85.44 M base_Shares
Invalid Date
85.44 M base_Shares
Price targets and forecasts for EMvision Medical Devices are not yet available.

EMvision Medical Devices shareholder structure

% Name
8.02048%
Keysight Technologies Inc
Keysight Technologies Inc
4.60188%
Kirkland (Scott)
Kirkland (Scott)
3.21713%
Laws (Ryan)
Laws (Ryan)
2.62177%
HUB24 Limited
HUB24 Limited
2.22366%
Keep (John)
Keep (John)
1.76367%
Weinberger (Ronald Peter)
Weinberger (Ronald Peter)
1.60318%
Brown (Paul Raymond)
Brown (Paul Raymond)
1.32343%
JM Starcevich Investments Pty. Ltd.
JM Starcevich Investments Pty. Ltd.
1.29116%
Uniquest Pty. Ltd.
Uniquest Pty. Ltd.
1.24812%
Busso Holdings Pty. Ltd.
Busso Holdings Pty. Ltd.

EMvision Medical Devices Executives and Management Board

PD

Dr. Philip Dubois

(76)

Independent Non-Executive Director

Compensation396,806 AUD
SK

Mr. Scott Kirkland

Chief Executive Officer, Managing Director, Executive Director · since 2023

Compensation270,000 AUD
JK

Mr. John Keep

Non-Executive Chairman of the Board

Compensation113,667 AUD
TK

Mr. Tony Keane

Independent Non-Executive Director

Compensation55,000 AUD
FK

Ms. Forough Khandan

Chief Technology Officer

Frequently asked questions about EMvision Medical Devices

All fundamentals and in-depth analysis of EMvision Medical Devices

Our stock analysis for EMvision Medical Devices Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of EMvision Medical Devices Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.